Bay Area Research Logistics is known for its superior management of all components of clinical trial logistics, from drug procurement to blinding, packaging, labeling, storing and distribution. Bay Area Research Logistics has developed or assisted in the design and packaging for all phases of clinical trials, ranging from pilot studies through Phase IV clinical trials.
Clinical Trial Planning
Each clinical trial is assigned a Trial Coordinator with experience in clinical research. The Trial Coordinator gains a thorough understanding of the client’s needs and requirements, whether it be for a domestic feasibility trial or a large, Phase IV international trial. This person assumes responsibility for all of the technical and administrative aspects of the study.
Clinical Trial Labeling
Products for primary and secondary packaging and labeling are checked to confirm the contents, and then appropriately labeled for storage. We securely package and label each lot of printed packaging material, including with a unique lot number for traceability. Certain protocols are followed depending on whether trials are blinded or open label.
Clinical Trial Storage
Bay Area Research Logistics has the expertise and capacity to store and ship clinical trial drugs at ambient, refrigerated, frozen and ultra-low frozen temperatures.
Clinical Trial Packaging
BARL provides primary and secondary packaging and labeling in a fully cGMP compliant facility. We are able to execute both large and small packaging runs quickly and accurately, within tight deadlines. Our clients are provided with responsive and flexible packaging schedules, and on-time delivery with precision and accuracy.
Clinical Trials Innovation Programme 2022
Clinical Trials Innovation Programme is an invitation-only, premium event bringing together a mix of clinical research professionals and service providers in one stimulating environment.
Join us face to face to learn from the best in the drug development industry and have an opportunity to learn from their experiences. With an agenda covering the future of Clinical trials and drug development post COVID, Clinical Trials Innovation Programme 2022 will feature tailored sessions presented by the leading experts from across the globe.
We are bringing together the best in the industry to help you learn and grow, and accelerate your drug development journey. The experts will include thought leaders and visionaries from Danish Medicines Agency, Bayer Pharmaceuticals, AstraZeneca, The Janssen Pharmaceutical Companies of Johnson & Johnson, Travere Therapeutics, Biogen, Vifor Pharma, Medical Products Agency and much more. Register with us to learn more!